Suggestions
Ephraim Heller
Executive Chairman and Board Member
Ephraim Heller is a prominent entrepreneur and investor in the healthcare sector, currently recognized for his role as the Chairman of the Board at Nitrome Biosciences. He holds a degree in Physics from Harvard University and an MBA from Yale School of Management. Heller has extensive experience in biomedical engineering and has co-founded several healthcare companies, including SynAgile Corporation, AngioScore, and TheraSense Inc..1
At Nitrome Biosciences, where he served as Chairman from January 2018 to April 2020, Heller was instrumental in the company's development of drugs targeting a new class of enzymes, particularly for conditions like Parkinson's disease. Under his leadership, the company successfully completed a $38 million Series A financing round.12 He has also held significant positions in other companies focused on medical technology and devices, showcasing his commitment to improving patient diagnostics and treatment through innovative solutions.1
